1. Corti, C, Xuereb, J H, Corsi, M, Ferraguti, F. . Identification and characterization of the promoter region of the GRM3 gene. In Biochemical and biophysical research communications, 286, 381-7. doi:. https://pubmed.ncbi.nlm.nih.gov/11500049/
2. Bishop, Jeffrey R, Reilly, James L, Harris, Margret S H, Keshavan, Matcheri S, Sweeney, John A. 2014. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia. In Psychopharmacology, 232, 145-54. doi:10.1007/s00213-014-3649-4. https://pubmed.ncbi.nlm.nih.gov/25096017/
3. Yi, H, Geng, L, Black, A, Berim, L, Wang, J. 2017. The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis. In Oncogene, 36, 3477-3489. doi:10.1038/onc.2016.499. https://pubmed.ncbi.nlm.nih.gov/28114282/
4. Saini, S M, Mancuso, S G, Mostaid, Md S, Everall, I P, Bousman, C A. 2017. Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. In Translational psychiatry, 7, e1196. doi:10.1038/tp.2017.172. https://pubmed.ncbi.nlm.nih.gov/28786982/
5. Bishop, Jeffrey R, Miller, Del D, Ellingrod, Vicki L, Holman, Timothy. . Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia. In Human psychopharmacology, 26, 28-34. doi:. https://pubmed.ncbi.nlm.nih.gov/21344500/
6. Neto, Ana, Ceol, Craig J. 2017. Melanoma-associated GRM3 variants dysregulate melanosome trafficking and cAMP signaling. In Pigment cell & melanoma research, 31, 115-119. doi:10.1111/pcmr.12610. https://pubmed.ncbi.nlm.nih.gov/28646617/
7. Ma, Ning, Liu, Xiaoling, Xing, Chen, Xiao, He, Wang, Renxi. 2015. Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells. In Clinical immunology (Orlando, Fla.), 160, 142-54. doi:10.1016/j.clim.2015.05.016. https://pubmed.ncbi.nlm.nih.gov/26071318/
8. Norton, Nadine, Williams, Hywel J, Dwyer, Sarah, O'Donovan, Michael C, Owen, Michael J. 2005. No evidence for association between polymorphisms in GRM3 and schizophrenia. In BMC psychiatry, 5, 23. doi:. https://pubmed.ncbi.nlm.nih.gov/15892884/